Drug and Alcohol Dependence

Papers
(The TQCC of Drug and Alcohol Dependence is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES323
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS270
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS153
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial133
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment115
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives113
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS73
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus73
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine66
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study57
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study56
Clinical Translation of the HR/LR Model of SUD Propensity53
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments51
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS51
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization49
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes49
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder49
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents47
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs46
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder45
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats44
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)44
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs44
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents42
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic42
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder41
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada40
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats40
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose39
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor38
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist38
Relationship perceptions and conflict behavior among cannabis users37
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years37
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder37
Longitudinal patterns of opioid and stimulant use by route of administration among people who inject drugs in the South Atlantic Fentanyl Test Strip Study: A latent transition analysis36
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–201936
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers36
Rising opioid-associated skin and soft tissue infections and the emerging threat of xylazine: A national analysis36
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder35
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity35
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder34
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs34
Health care provider decision-making around prenatal substance use reporting34
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine33
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults33
XYLAZINE: AN ADULTERANT DRUG OF CONCERN33
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan33
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY33
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment32
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone31
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine31
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy31
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market31
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use31
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women30
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder30
Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users30
Substance-induced mental disorders and discontinuation of medication for opioid use disorder29
Punishment of ethanol choice in group-housed male cynomolgus monkeys29
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge29
Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State29
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS29
Editorial Board29
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors28
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)28
Editorial Board28
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis28
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study28
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs27
Cannabis use and subjective response to alcohol in the human laboratory27
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?27
The centrality of craving in network analysis of five substance use disorders27
Correlates of solitary alcohol and cannabis use among American Indian adolescents27
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–1727
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–201127
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury27
Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: A longitudinal analysis27
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence27
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis26
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach26
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study26
Validation of a single question for the assessment of past three-month alcohol consumption among adolescents26
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]26
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys26
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?26
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand25
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults25
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX25
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial25
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS25
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?24
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data24
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–202124
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration24
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT24
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland24
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling23
“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use23
Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico23
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment23
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration23
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora23
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario23
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose22
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research22
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors22
Editorial Board22
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets22
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans22
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder22
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-201922
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems22
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data22
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations22
Depression Outcomes Among Women Participating in Worth Transitions22
Assessing inequities in buprenorphine treatment across the care cascade22
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics21
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA21
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids21
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention21
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE21
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers21
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida21
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism21
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS21
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM21
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada21
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS21
Substance Co-Exposure Among Women With Opioid Use During Pregnancy20
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort20
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months20
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users20
Primary Form of Cannabis Use and Recent Negative Affect Symptoms20
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder20
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder20
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain20
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement20
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial20
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication20
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process20
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic19
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement19
Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada19
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food19
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study19
MEDIA FORUM19
Methodology for Single- vs Polydrug Classification of Poisoning Deaths19
Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study19
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery19
Differences in tobacco smoking and alcohol consumption among 57,757 women from early to late pregnancy: A state-representative study in Queensland, Australia19
Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)19
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse18
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder18
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL18
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-202118
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care18
Impacts of impaired control and pharmacological criteria for lifetime alcohol use disorder on relationships between drinking and problems18
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers18
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT18
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program18
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure18
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study18
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder18
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine18
Structural indices of brain aging in methamphetamine use disorder17
State marijuana policies and vaping associated lung injuries in the US17
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting17
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction17
The socioeconomic, health, and family situation of adult siblings of patients with substance use diagnosis: A descriptive registry study17
Prospective association between screen use modalities and substance use experimentation in early adolescents17
Editorial Board17
Editorial Board17
Cross sectional multi-sample study of nonfatal overdose in adolescents and young adults in the fentanyl era17
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk17
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes17
Deficits in consummatory reward relate to severity of cocaine use17
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States16
School party culture as a driver of cocaine use among Norwegian adolescents: A cross-classified multilevel analysis16
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study16
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system16
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)16
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers16
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns16
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study16
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa16
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications16
The defining characteristic of substance use disorders16
Mirtazapine reduces hypothetical methamphetamine demand in humans16
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality16
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies16
Assessment of substance exposures in nail clipping samples: A systematic review16
How has the brain disease model of addiction contributed to tobacco control?16
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product16
Adolescent depression symptoms and e-cigarette progression16
Latent profiles of impulsivity facets and associations with drinking behaviors16
An investigation of multimodal predictors of adolescent alcohol initiation16
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders15
Trends in poisonings involving ketamine in the United States, 2019–202315
Intimate partner violence is related to future alcohol use among a nationwide sample of LGBTQIA+ people: Results from The PRIDE Study15
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City15
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment15
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes15
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis15
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY15
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial15
Editorial Board15
Clustering of risk behaviors and classification performance in modeling adolescent risk: The example of the association between E-cigarette use and cigarette smoking15
Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances15
Gender Differences in Smoking Dependence Motives15
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity15
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review15
Legality of drug checking equipment in the United States: A systematic legal analysis15
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report15
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System15
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting15
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders14
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder14
Editorial Board14
Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study14
Depressive symptoms predict cannabis vaping initiation among young adults14
FACTORS LINKED WITH PSYCHOLOGICAL DISTRESS IN A DIVERSE SAMPLE OF SUBSTANCE-USING ADULTS IN THE SOUTHEASTERN U.S.14
NEUROLOGICAL AND BEHAVIORAL CHANGES 6 MONTHS AFTER GASTRIC SLEEVE METABOLIC SURGERY14
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone14
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers14
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients14
A Crisis Within a Crisis: Accelerating Racial Disparities in the US Overdose Epidemic14
Who participates in the ‘Celebrate Recovery’ mutual-help organization? Results from a National US Investigation14
Association between gender diversity and substance use experimentation in early adolescents14
An economic analysis of community costs incurred to implement the communities that HEAL intervention to reduce opioid overdose deaths in four states14
Editorial Board14
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi14
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency14
Stimulant use, HIV, and immune dysregulation among sexual minority men14
Adolescent alcohol initiation: Context of close friendships and the role of trust14
A Survey of Chronic Pain Patients regarding Drug Use and Opinions on Brain Stimulation as Treatment14
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats14
The Peers Expanding Engagement in Stimulant Harm Reduction With Contingency Management Study14
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH14
Heightened Insula Signal but Reduced Interoceptive Awareness is Linked to Relapse in Opioid Use Disorder: Preliminary Findings13
10 Hz Excited DLPFC, but Not 1 Hz Inhibited Mofc Induced Smoking Cessation: A Randomized Repetitive Transcranial Magnetic Stimulation Trial13
Alcohol Use and Racial Discrimination in Later Generations of Latine Immigrants13
Lifetime and 30-Day Drug Use Associated With Higher by FTND Scores13
Older Adults in Opioid Use Disorder Treatment: A Systematic Review of Health Outcomes13
The Role of Substance Use on ART Adherence Among Black People With HIV13
HARM REDUCTION SUPPLY DISTRIBUTION VIA VENDING MACHINES: 6-MONTH OUTCOMES FOR A CALIFORNIA VETERANS AFFAIRS HEALTH CARE SYSTEM13
Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey13
Development and Validation of Machine-Learning Algorithms Predicting Retention, Overdoses, and All-Cause Mortality Among US Military Veterans Treated with Buprenorphine for Opioid Use Disorder13
Assessing the Association Between Increased Student-Adult Connections, Perceptions of School, and Substance Misuse Rates Among Justice-Involved Adolescents13
Examining Engagement in Contingency Management for Smoking Cessation Among Homeless-Experienced Veterans: The Role of Dual Diagnosis13
Integrating MOUD in Non-Medical Community Organizations: Better Together MOUD (BT-MOUD)13
0.17297196388245